A newsletter by Reuters and Westlaw

By Sara Merken

What's going on today?

REUTERS/Dado Ruvic/Illustration/File Photo

Artificial intelligence is pretty good at taking law school exams, according to a growing body of research. Should it be used to grade them?

Six law professors from across the country put OpenAI’s ChatGPT-5 to the test, using it to grade final written exams from four different subjects and comparing its results to human professors. ChatGPT’s grades were “roughly approximate” to those of the professors, especially when the program was given a detailed grading rubric, the researchers found. Read the study here.

While the human and AI grades were similar, study co-author Daniel Schwarcz said it's impossible to know which did a better job evaluating the essay-style exams. “It's entirely possible that AI grades were actually more ‘accurate’ in evaluating the quality of exam answers than were human grades,” said Schwarcz.

Karen Sloan has the story.

REUTERS/Gaelen Morse/File Photo

A divided U.S. Supreme Court wrestled with a Republican-led bid to strike down on free speech grounds federal limits on spending by political parties in coordination with candidates in a case involving Vice President JD Vance.

At least four of the six conservative justices appeared sympathetic toward the challenge during more than two hours of argument in the case, with the court's three liberal members seeming inclined to preserve the spending limits. Read more from John Kruzel and Andrew Chung.

If you're enjoying the stories featured in this newsletter, don't forget that a Reuters subscription gives you unlimited access to all stories and fewer ads. Plus, no surprise price increases and you can cancel anytime. Sign up here.

President Trump's approval rating edged up to 41% in the past week as Republicans warmed to his handling of the cost of living … Jared Kushner's financing role in Paramount's $108 billion bid for Warner Bros raises ethical questions, experts say … China's Premier Li Qiang urged trading partners to reject rising protectionism … Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo Nordisk to manage the hormonal disorder's symptoms … Business is booming for defense contractors.